These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 5333788)
1. [Treatment of osteoporosis with an enolic ether of dihydrotestosterone. (Clinical studies)]. Domeniconi S Chir Organi Mov; 1966; 54(5):409-14. PubMed ID: 5333788 [No Abstract] [Full Text] [Related]
2. Clinical findings on the therapeutic action of a long-acting anabolic agent. Luppino V Panminerva Med; 1965 Oct; 7(10):392-8. PubMed ID: 5320934 [No Abstract] [Full Text] [Related]
3. Bone anabolic agents: the unanswered queries. Adami S; Viapiana O; Gatti D Basic Clin Pharmacol Toxicol; 2004 Jun; 94(6):257-9. PubMed ID: 15228496 [No Abstract] [Full Text] [Related]
4. [Anabolic therapy of osteoporosis]. Okopień B; Krysiak R; Labuzek K; Herman ZS Pol Merkur Lekarski; 2005 Jul; 19(109):118-21. PubMed ID: 16194044 [TBL] [Abstract][Full Text] [Related]
5. [On the therapy of osteoporosis with anabolic steroids]. Krüskemper HL Verh Dtsch Ges Inn Med; 1965; 71():590-6. PubMed ID: 5877670 [No Abstract] [Full Text] [Related]
6. [Therapy of osteoporosis]. Kuhlencordt F Dtsch Med J; 1966 May; 17(9):241-7. PubMed ID: 5984282 [No Abstract] [Full Text] [Related]
7. [Experience with anabolic steroid therapy in osteoporosis]. Müller G Z Arztl Fortbild (Jena); 1973 Mar; 67(6):277-9. PubMed ID: 4716646 [No Abstract] [Full Text] [Related]
8. Combination of anabolic and antiresorptive agents for the treatment of osteoporosis. Garcés C; García LE Maturitas; 2006 Apr; 54(1):47-54. PubMed ID: 16257150 [TBL] [Abstract][Full Text] [Related]
9. [Clinical experiences with a new anabolic steroid: 2-formyl-17(alpha)methylandrosta-1,4-dien-11(alpha)17(beta)diol-3-one]. Pardini C; Terreni F Clin Ter; 1971 Aug; 58(4):343-50. PubMed ID: 5158278 [No Abstract] [Full Text] [Related]
10. The treatment of osteoporosis. Melick RA Med J Aust; 1986 Jun; 144(12):645-7. PubMed ID: 3520261 [No Abstract] [Full Text] [Related]
12. [Human pharmacological study of quinbolone. Clinical and laboratory investigations of the effects of anabolic treatment in aged women]. Mezzena R; Foresti M; Trisotto M; Bruni G G Gerontol; 1972 Apr; 20(4):361-78. PubMed ID: 5042390 [No Abstract] [Full Text] [Related]
13. New and emerging treatments for osteoporosis. Clarke BL Clin Endocrinol (Oxf); 2009 Sep; 71(3):309-21. PubMed ID: 19222491 [TBL] [Abstract][Full Text] [Related]
14. Prevention and treatment of postmenopausal and "senile" osteoporosis. Med Lett Drugs Ther; 1969 Dec; 11(25):101-3. PubMed ID: 5375105 [No Abstract] [Full Text] [Related]
15. [Studies of the spontanoeus vertebral deformities in osteoporosis]. Mach J Beitr Orthop Traumatol; 1968 Apr; 15(4):227-33. PubMed ID: 5711567 [No Abstract] [Full Text] [Related]
16. [Current problems in the treatment of osteoporosis]. Verniory JP; Lambert H; Rosenbusch CA; Junet R Maroc Med; 1967 Feb; 47(499):80-4. PubMed ID: 5600311 [No Abstract] [Full Text] [Related]
17. Teriparatide (biosynthetic human parathyroid hormone 1-34): a new paradigm in the treatment of osteoporosis. Brixen KT; Christensen PM; Ejersted C; Langdahl BL Basic Clin Pharmacol Toxicol; 2004 Jun; 94(6):260-70. PubMed ID: 15228497 [TBL] [Abstract][Full Text] [Related]
18. [Clinical experience with dihydrotestosterone N-optyl enol ether in diffuse breast cancer]. Cozzi PA; Paiani P Friuli Med; 1966; 21(3):369-78. PubMed ID: 5985682 [No Abstract] [Full Text] [Related]
19. [The treatment of osteoporosis by trophobolene]. Vignon G; Pansu D Rev Lyon Med; 1967 Jan; 16(1):31-8. PubMed ID: 5595570 [No Abstract] [Full Text] [Related]